245 related articles for article (PubMed ID: 8768004)
41. [Recent progress in the treatment of hematological malignancies. II. Chemotherapy of relapsed and refractory acute myeloid leukemia in adult].
Ohshima T
Nihon Naika Gakkai Zasshi; 1989 Jun; 78(6):774-80. PubMed ID: 2794659
[No Abstract] [Full Text] [Related]
42. Long-term survival of patients with acute myeloid leukemia: a third follow-up of the Fourth International Workshop on Chromosomes in Leukemia.
Bloomfield CD; Shuma C; Regal L; Philip PP; Hossfeld DK; Hagemeijer AM; Garson OM; Peterson BA; Sakurai M; Alimena G; Berger R; Rowley JD; Ruutu T; Mitelman F; Dewald GW; Swansbury J
Cancer; 1997 Dec; 80(11 Suppl):2191-8. PubMed ID: 9395033
[TBL] [Abstract][Full Text] [Related]
43. [Efficacy and safety of induction chemotherapy consisting of anthracycline for 3 days and cytarabine for 7 days in elderly patients with acute myeloid leukemia].
Kurahashi S; Iwasaki T; Suzuki H; Sawamoto A; Sugimoto T; Narimatsu H; Adachi T; Hayakawa F; Sugiura I
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1617-21. PubMed ID: 17940376
[TBL] [Abstract][Full Text] [Related]
44. Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia.
Baz R; Rodriguez C; Fu AZ; Jawde RA; Kalaycio M; Advani A; Sobecks R; Sekeres MA
Cancer; 2007 Oct; 110(8):1752-9. PubMed ID: 17724726
[TBL] [Abstract][Full Text] [Related]
45. Second malignancy after treatment of adult acute myeloid leukemia: cohort study on adult patients enrolled in the GIMEMA trials.
Pagano L; Pulsoni A; Tosti ME; Caramatti C; Cerri R; Falcucci P; Fazi P; Fianchi L; Martino B; Mattei D; Offidani M; Pacilli L; Pogliani EM; Rotoli B; Specchia G; Visani G; Vignetti M; Voso MT; Leone G; Mandelli F;
Leukemia; 2004 Mar; 18(3):651-3. PubMed ID: 14749702
[No Abstract] [Full Text] [Related]
46. [Prognostic significance of age and karyotype in the treatment of acute myeloid leukemia: results at our center].
Nahajevszky S; Kapás B; Adám E; Lovas N; Halm G; Gopcsa L; Tamáska J; Poros A
Orv Hetil; 2004 Jan; 145(4):167-72. PubMed ID: 14978882
[TBL] [Abstract][Full Text] [Related]
47. [Current status of complete remission rate of acute leukemia in Shanghai].
Shanghai Leukemia Cooperative Group Shanghai 200040 China
Zhonghua Xue Ye Xue Za Zhi; 2000 Jan; 21(1):17-9. PubMed ID: 11876954
[TBL] [Abstract][Full Text] [Related]
48. The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement.
Castagnola C; Nozza A; Corso A; Bernasconi C
Haematologica; 1997; 82(5):577-80. PubMed ID: 9407724
[TBL] [Abstract][Full Text] [Related]
49. [Childhood acute myeloblastic leukemias. Report of 21 cases].
Laatiri MA; Chehata S; Amouri A; Bouaouina N; Chatti S; Saad A; Ennabli S
Tunis Med; 2000 Mar; 78(3):167-71. PubMed ID: 11026819
[TBL] [Abstract][Full Text] [Related]
50. Disease biology rather than age is the most important determinant of survival of patients > or = 60 years with acute myeloid leukemia treated with uniform intensive therapy.
Gupta V; Chun K; Yi QL; Minden M; Schuh A; Wells R; Brandwein J
Cancer; 2005 May; 103(10):2082-90. PubMed ID: 15830348
[TBL] [Abstract][Full Text] [Related]
51. The outcome of intensive induction therapy in patients >or=70 years with acute myeloid leukemia.
Gupta V; Xu W; Keng C; Alibhai SM; Brandwein J; Schimmer A; Schuh A; Yee K; Minden MD
Leukemia; 2007 Jun; 21(6):1321-4. PubMed ID: 17344911
[No Abstract] [Full Text] [Related]
52. Improved outcome in acute myeloid leukemia patients enrolled in clinical trials: A national population-based cohort study of Danish intensive chemotherapy patients.
Østgård LS; Nørgaard M; Sengeløv H; Medeiros BC; Kjeldsen L; Overgaard UM; Severinsen MT; Marcher CW; Jensen MK; Nørgaard JM
Oncotarget; 2016 Nov; 7(44):72044-72056. PubMed ID: 27732947
[TBL] [Abstract][Full Text] [Related]
53. [Acute myeloid leukemia: from risk-adapted to genotype-specific therapy].
Kayser S; Schlenk RF
Dtsch Med Wochenschr; 2011 Aug; 136(31-32):1577-80. PubMed ID: 21809245
[No Abstract] [Full Text] [Related]
54. [Effect of treatment of leukemia on blast transformation of leukemia cells in vitro].
Kiersnowska-Rogowska B; Rogowski F; Giedrojć J; Bielawiec M
Pol Tyg Lek; 1987 Aug; 42(33):1005-7. PubMed ID: 3480508
[No Abstract] [Full Text] [Related]
55. Acute Myeloid Leukemia Diagnosed 5 Years after Adult T-Cell Leukemia/Lymphoma.
Owatari S; Arai A; Tsuruta T; Haraguchi K; Otsuka M; Hanada S
J Clin Exp Hematop; 2015; 55(1):29-31. PubMed ID: 26106004
[TBL] [Abstract][Full Text] [Related]
56. Venetoclax and hypomethylating agent combination therapy in acute myeloid leukemia secondary to a myeloproliferative neoplasm.
Tremblay D; Feld J; Dougherty M; Czaplinska T; Sanchez G; Kremyanskaya M; Bar-Natan M; Shih AH; Keyzner A; Mascarenhas J
Leuk Res; 2020 Nov; 98():106456. PubMed ID: 33002673
[No Abstract] [Full Text] [Related]
57. The Leser-Trelat sign is a associated with acute myeloid leukemia.
Yavasoglu I; Kadikoylu G; Bolaman Z
Ann Hematol; 2011 Mar; 90(3):363. PubMed ID: 20703879
[No Abstract] [Full Text] [Related]
58. Factors effecting remission and survival in adult acute nonlymphocytic leukemia (ANLL).
Wiernik PH; Serpick AA
Medicine (Baltimore); 1970 Nov; 49(6):505-13. PubMed ID: 5286084
[No Abstract] [Full Text] [Related]
59. More on the treatment of relapsed acute myeloid leukemia.
Capizzi RL
Oncology (Williston Park); 1989 Oct; 3(10):72-4. PubMed ID: 2701211
[No Abstract] [Full Text] [Related]
60. Philadelphia chromosome-negative acute leukemia in patients with chronic myeloid leukemia.
Gong Z; Xu ML; Chen M; Cui W; Kantarjian HM; Cortes JE; Zhou T; Tang G; Wang W; Medeiros LJ; Hu S
Am J Hematol; 2019 Oct; 94(10):E256-E259. PubMed ID: 31273842
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
